Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Disease Models & Mechanisms|August 4, 2025
Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strainsEglė Žymantaitė, Migle Gabrielaite, Vita Pašukonienė, et al.Vaccine|May 20, 2014
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use?Marius M Strioga, Adas Darinskas, Vita Pasukoniene, et al.Frontiers in Immunology|March 31, 2025
Targeting stemness pathways modulates macrophage polarization and reprograms the tumor microenvironmentAusteja Butkute, Marius Baltramonaitis, Simona Malmige, et al.Medicina (Kaunas, Lithuania)|December 18, 2015
Evaluation of low-dose proton beam radiation efficiency in MIA PaCa-2 pancreatic cancer cell line vitality and H2AX formationAušra Liubavičiūtė, Jan Aleksander Kraśko, Agata Mlynska, et al.International Journal of Nanomedicine|August 13, 2025
Unveiling Theranostics: Nanocomplex-Assisted Photodynamic Eradication of Aggressive Cancer Cells and Modulation of Tumor-Associated MacrophagesAusteja Butkute, Evelina Kazlauske, Agata Mlynska, et al.International Journal of Molecular Sciences|January 25, 2025
Liquid-Based Diagnostic Panels for Prostate Cancer: The Synergistic Role of Soluble PD-L1, PD-1, and mRNA BiomarkersMargarita Žvirblė, Ieva Vaicekauskaitė, Žilvinas Survila, et al.Frontiers in Immunology|July 26, 2024
Prognostic significance of soluble PD-L1 in prostate cancerMargarita Zvirble, Zilvinas Survila, Paulius Bosas, et al.Cancer Immunology, Immunotherapy : CII|April 2, 2022
Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor modelsKarolina Žilionytė, Ugnė Bagdzevičiūtė, Agata Mlynska, et al.Bioengineering (Basel, Switzerland)|September 27, 2024
Advancing 3D Spheroid Research through 3D Scaffolds Made by Two-Photon PolymerizationEglė Vitkūnaitė, Eglė Žymantaitė, Agata Mlynska, et al.Journal of Clinical Medicine|August 27, 2021
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer PatientsPaulius Bosas, Gintaras Zaleskis, Daiva Dabkevičiene, et al.Pageof 3